Relationship Between Bone Mineral Density and Androgen-deprivation Therapy in Japanese Prostate Cancer Patients
Takeshi Yuasa(Japanese Foundation For Cancer Research), Tomonori Habuchi(Akita University), Norihiko Tsuchiya(Yamagata University), Iwao Fukui(Japanese Foundation For Cancer Research), Kiyohiko Hatake(Nara Medical University), Yohei Horikawa(Akita University), Shintaro Narita(Akita University), Shinya Yamamoto, Junji Yonese, Zhiyong Ma(Shanghai Veterinary Research Institute), Shinya Maita(Akita University), Shunji Takahashi(Japanese Foundation For Cancer Research)
Cited by 20
Related Papers
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
|New England Journal of Medicine|2020|1.5k
Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract.
|PubMed|1998|176
Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study
|Annals of Oncology|2022|148
STING aggravates ferroptosis-dependent myocardial ischemia-reperfusion injury by targeting GPX4 for autophagic degradation
|Signal Transduction and Targeted Therapy|2025|127
Accumulated allelic losses in the development of invasive urothelial cancer
|International Journal of Cancer|1993|116